title: Summary of the 2016 American Association for Cancer Research (AACR) Annual Meeting.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University in St. Louis, USA.
authors.forename: Katherine
authors.initials: K
authors.lastname: Fuh
authors.affiliation: Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine, USA; Department of Immunology, University of Pittsburgh School of Medicine, USA.
authors.forename: Anda M
authors.initials: AM
authors.lastname: Vlad
authors.affiliation: Department of Obstetrics and Gynecology, Women's Oncology Program, University of Virginia Cancer Center, USA. Electronic address: clanden@virginia.edu.
authors.forename: Charles N
authors.initials: CN
authors.lastname: Landen
mesh_terms: D000818:Animals; D035843:Biomedical Research; D064113:CRISPR-Cas Systems; D004195:Disease Models, Animal; D019008:Drug Resistance, Neoplasm; D044127:Epigenesis, Genetic; D005260:Female; D000072669:Gene Editing; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009369:Neoplasms / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D000067856:Poly(ADP-ribose) Polymerase Inhibitors / Q000627:therapeutic use; D015996:Survival Rate; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control
chemical_list: D000067856:Poly(ADP-ribose) Polymerase Inhibitors
keywords: Chemoresistance; Immunotherapy; Moonshot; Personalized therapy; Preclinical models; Tumor heterogeneity